Zhihong Yang Selected Research

Ureohydrolases

1/2021

Hypoxia Induces Renal Epithelial Injury and Activates Fibrotic Signaling Through Up-Regulation of Arginase-II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhihong Yang Research Topics

Disease

38	Neoplasms (Cancer) 03/2021 - 02/2010
21	Inflammation (Inflammations) 01/2022 - 03/2009
11	Atherosclerosis 01/2019 - 02/2003
10	Obesity 01/2020 - 11/2005
10	Carcinogenesis 12/2019 - 04/2010
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2011
7	Body Weight (Weight, Body) 01/2020 - 01/2008
6	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2007
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2019
6	Insulin Resistance 07/2014 - 01/2008
5	Liver Diseases (Liver Disease) 11/2021 - 08/2017
5	Fibrosis (Cirrhosis) 03/2021 - 12/2017
5	Retinopathy of Prematurity (Retrolental Fibroplasia) 11/2018 - 09/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2015
4	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 10/2011
4	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2010
4	Liver Neoplasms (Liver Cancer) 10/2017 - 04/2012
4	Lung Neoplasms (Lung Cancer) 08/2017 - 03/2011
4	Acute Coronary Syndrome 01/2017 - 04/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 01/2014
3	Cholestasis 01/2021 - 01/2017
3	Non-alcoholic Fatty Liver Disease 12/2017 - 02/2016
3	Glucose Intolerance 01/2017 - 01/2008
3	Thrombosis (Thrombus) 01/2017 - 07/2005
3	Type 2 Diabetes Mellitus (MODY) 06/2013 - 06/2010
2	Alcoholic Hepatitis 01/2022 - 01/2022
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2022 - 08/2017
2	Hepatitis 11/2021 - 10/2020
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Ischemia 01/2021 - 07/2009
2	Infections 12/2020 - 09/2003
2	Sclerosing Cholangitis 11/2020 - 10/2019
2	Albuminuria 01/2020 - 01/2018
2	Ischemic Stroke 08/2019 - 06/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2019 - 07/2013
2	Hypertrophy 01/2018 - 02/2003
2	Fatty Liver 01/2018 - 03/2015
2	Cataract (Cataracts) 01/2017 - 01/2017
2	Necrosis 01/2017 - 05/2012
2	Vomiting 06/2016 - 04/2010
2	Pathologic Neovascularization 04/2014 - 02/2014
2	Weight Gain 02/2014 - 09/2013

Drug/Important Bio-Agent (IBA)

18	ArginaseIBA 01/2021 - 12/2004
12	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
8	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2015
8	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2010
7	Arginine (L-Arginine)FDA Link 01/2021 - 07/2013
6	Messenger RNA (mRNA)IBA 11/2020 - 09/2016
6	Insulin (Novolin)FDA Link 09/2019 - 01/2008
5	EnzymesIBA 01/2021 - 03/2009
5	Pharmaceutical PreparationsIBA 12/2020 - 04/2014
5	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 09/2020 - 01/2017
5	Transcription Factors (Transcription Factor)IBA 05/2019 - 02/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 09/2013
5	Thromboplastin (Tissue Factor)IBA 01/2017 - 04/2004
5	Tocopherols (Tocopherol)IBA 09/2013 - 04/2010
5	Vitamin E FDA LinkGeneric 06/2013 - 04/2010
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
4	Long Noncoding RNAIBA 01/2021 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2012
4	Small Interfering RNA (siRNA)IBA 11/2020 - 09/2013
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019 - 03/2009
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 03/2005
4	Biological ProductsIBA 01/2017 - 01/2012
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2016 - 01/2012
4	Retinaldehyde (Retinal)IBA 04/2014 - 09/2013
4	Apolipoproteins E (ApoE)IBA 01/2014 - 03/2005
4	PolyphenolsIBA 06/2013 - 03/2009
3	AMP-Activated Protein KinasesIBA 01/2022 - 01/2014
3	Ethanol (Ethyl Alcohol)IBA 01/2022 - 05/2015
3	ChemokinesIBA 03/2021 - 01/2020
3	CatalaseIBA 12/2020 - 01/2018
3	MorpholinosIBA 11/2020 - 10/2019
3	VimentinIBA 10/2019 - 04/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019 - 03/2009
3	LipidsIBA 01/2019 - 03/2015
3	Superoxides (Superoxide)IBA 01/2019 - 03/2009
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2010
3	AntioxidantsIBA 01/2018 - 03/2009
3	Cisplatin (Platino)FDA LinkGeneric 06/2016 - 04/2010
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2014 - 03/2009
3	Oxygen (Dioxygen)IBA 04/2014 - 03/2011
3	Estrogen ReceptorsIBA 08/2013 - 02/2007
3	ApolipoproteinsIBA 07/2013 - 03/2005
3	TeaIBA 06/2013 - 05/2010
3	Atorvastatin (Lipitor)FDA Link 08/2012 - 02/2010
2	RotenoneIBA 01/2021 - 01/2019
2	Superoxide DismutaseIBA 12/2020 - 01/2010
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 11/2020 - 04/2010
2	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2018 - 01/2017
2	Aldehyde Reductase (Aldose Reductase)IBA 01/2017 - 01/2017
2	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 07/2014
2	SugarsIBA 01/2017 - 01/2017
2	AntiemeticsIBA 06/2016 - 04/2010
2	Protein Isoforms (Isoforms)IBA 02/2016 - 01/2014
2	TOR Serine-Threonine KinasesIBA 02/2016 - 01/2012
2	Periodic AcidIBA 01/2016 - 01/2015
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2015 - 04/2014

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2011
2	Photothermal Therapy 12/2018 - 06/2018